tiprankstipranks
Primo Nutraceuticals (BUGVF)
OTHER OTC:BUGVF
US Market

Primo Nutraceuticals (BUGVF) Financial Statements

9 Followers

Primo Nutraceuticals Financial Overview

Primo Nutraceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Primo Nutraceuticals is scheduled to report earnings on July 1, 2020, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 20Jan 20Oct 19Jul 19Apr 19
Income Statement-
Total Revenue--C$ 0.00C$ 0.00C$ 0.00
Gross Profit-----
EBITC$ -390.38KC$ -84.89KC$ -509.75KC$ -674.89KC$ -113.58K
EBITDAC$ -390.38KC$ -84.89KC$ -509.75KC$ -674.89KC$ -113.58K
Net Income Common StockholdersC$ -390.38KC$ -84.89KC$ -510.41KC$ -2.85MC$ -1.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 9.95KC$ 5.93KC$ 40.43KC$ 40.59KC$ 94.90K
Total AssetsC$ 3.20MC$ 3.38MC$ 3.46MC$ 2.48MC$ 2.78M
Total DebtC$ 465.93KC$ 444.74KC$ 403.12KC$ 596.60KC$ 378.49K
Net DebtC$ 455.98KC$ 438.81KC$ 362.69KC$ 556.01KC$ 283.60K
Total LiabilitiesC$ 2.64MC$ 2.40MC$ 2.48MC$ 3.03MC$ 2.34M
Stockholders EquityC$ 561.29KC$ 972.39KC$ 976.29KC$ -543.82KC$ 435.71K
Cash Flow-
Free Cash FlowC$ -434.73KC$ -184.03KC$ -482.27KC$ -156.94KC$ -95.95K
Operating Cash FlowC$ -434.73KC$ -184.03KC$ -482.27KC$ -310.63KC$ -95.95K
Investing Cash FlowC$ -15.82KC$ 14.85KC$ -125.45KC$ -66.40KC$ -110.25K
Financing Cash FlowC$ 454.56KC$ 168.72KC$ 607.57KC$ 346.29KC$ 237.25K
Currency in CAD

Primo Nutraceuticals Earnings and Revenue History

Primo Nutraceuticals Debt to Assets

Primo Nutraceuticals Cash Flow

Primo Nutraceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis